Learn more about diabetic retinopathy at drinsights.com.au. View the Lipidil® Product Information here.

Videos / Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes

Product Explainer

Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes

Description

In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).

NEXT LIVE Webcast

Days

Hours

Minutes

Seconds

Prof Andrew Sindone

An Update on Heart Failure in Primary Care

Dr Gabby Mahoney

Allergen Introduction – Practical Tips for GPs

Prof Kim Delbaere

Falls Prevention – A Practical, Evidence-Based Update on What Really Works

Dr Stephanie Daly

The New Dementia Test and How they Fit Into the Assessment and Management of the Patient with Cognitive Concerns

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

03 February 2026

expert

Prof Richard O'Brien

Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health

Product Explainer

Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes